Evofem Biosciences Inc (EVFM) USD0.0001

Sell:$0.01Buy:$0.01$0.00 (1.32%)

Prices delayed by at least 15 minutes
Sell:$0.01
Buy:$0.01
Change:$0.00 (1.32%)
Prices delayed by at least 15 minutes
Sell:$0.01
Buy:$0.01
Change:$0.00 (1.32%)
Prices delayed by at least 15 minutes

Company Information

About this company

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. The Company is commercializing its products to address unmet needs in women’s sexual and reproductive health. The Company’s first approved product, PHEXXI (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of over 12 pre-filled applicators and is applied 0-60 minutes before each act of intercourse. PHEXXI is a gel that works to prevent pregnancy without the use of hormones. PHEXXI prevents pregnancy by reducing sperm motility, inhibiting sperm from reaching the ovum to form a zygote. Using the PHEXXI telehealth platform, women can directly meet with a health care provider to determine their eligibility for a PHEXXI prescription. The Company also commercialized SOLOSEC (secnidazole) 2g oral granules, an antibiotic for the treatment of two sexual health diseases such as bacterial vaginosis and trichomoniasis.

Key people

Saundra L. Pelletier
Interim Chairman of the Board of Directors, President, Chief Executive Officer
Ivy Zhang
Chief Financial Officer, Secretary
Kim Kamdar
Independent Director
Tony O'Brien
Independent Director
Lisa Dale Rarick
Independent Director
Colin Rutherford
Independent Director
Click to see more

Key facts

  • EPIC
    EVFM
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US30048L3024
  • Market cap
    $1.06m
  • Employees
    32
  • Shares in issue
    113.36m
  • Exchange
    Over The Counter
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.